[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335873-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335873-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-pp2a-complex-disruptor-set-prompts-widespread-hypertranscription-of-growth-essential-genes-in-the-pancreatic-cancer-cells","CANCER - PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells","","Hyperactivation of oncogenic transcription is linked to epigenetic plasticity in cancer cells, yet the mechanisms governing SET-dependent transcription have remained unclear. This study shows that SET overexpression and CDK9 activation generate highly similar transcriptome signatures across multiple cancer cell lines. SET concentrates near transcription start sites, supports RNA transcription, and disrupts PP2A through binding PP2A-C and repelling PP2A-A from PP2A-C. Blocking PP2A activity enables SET to sustain Pol II CTD phosphorylation and drive mRNA transcription in pancreatic cancer cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-pp2a-complex-disruptor-set-prompts-widespread-hypertranscription-of-growth-essential-genes-in-the-pancreatic-cancer-cells/335873/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-pp2a-complex-disruptor-set-prompts-widespread-hypertranscription-of-growth-essential-genes-in-the-pancreatic-cancer-cells/335873.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about SET-dependent transcription?","Question",{"text":63,"@type":64},"The study asks what mechanisms underlie SET-dependent transcription, which have been unknown despite SET’s known association with chromatin-linked transcriptional activity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do SET and CDK9 relate based on transcriptome signatures?",{"text":68,"@type":64},"Overexpression of SET and CDK9 produces very similar transcriptome signatures across multiple cancer cell lines, suggesting convergence on a shared transcriptional program.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does PP2A play in the proposed mechanism?",{"text":72,"@type":64},"SET binds the PP2A-C subunit and disrupts PP2A-A/C interactions in transcription start site–proximal regions; blocking PP2A activity helps SET maintain Pol II CTD phosphorylation and activate mRNA transcription.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335873,1790198413,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","CANCER  \nPP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells  \nHe Xu1,2,3,4†, Di Wu1,2,3,4*†, Mingming Xiao1,2,3,4†, Yubin Lei5, Yalan Lei1,2,3,4,  \nXianjun Yu1,2,3,4*, Si Shi1,2,3,4*  \nHyperactivation of the oncogenic transcription reflects the epigenetic plasticity of the cancer cells. Su(var)3-9, enhancer of zeste, Trithorax (SET) was described as a nuclear factor that stimulated transcription from the chromatin template. However, the mechanisms of SET-dependent transcription are unknown. Here, we found that overexpression of SET and CDK9 induced very similar transcriptome signatures in multiple cancer cell lines. SET localized in the transcription start site (TSS)–proximal regions and supported the RNA transcription. SET specifically bound the PP2A-C subunit and induced PP2A-A subunit repulsion from the C subunit, which indicated the role of SET as a PP2A-A/C complex disruptor in theTSS-proximal regions. Through blocking PP2A activity, SET assisted CDK9 to maintain Pol IICTD phosphorylation and activated mRNA transcription. Our findings position SET as a key factor that modulates chromatin PP2A activity, promoting the oncogenic transcription in the pancreatic cancer.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nNonmutational epigenetic reprogramming is increasingly discussed as a driving force in tumorigenesis (1–3) . Several lines of evidence have indicated the existence of global enhancement of transcription that favors the cancer growth. For instance, c-Myc up-regulation has long been identified as a cancer “driver”(4, 5) and c-Myc was found to amplify almost all the mRNA-transcribing genes in cancer cells (6) . For another example, aberrant activation of super-enhancers, which associated with the hypertranscription of massive critical oncogenes, was observed in multiple cancers (7–15) . Histone acetylation reader BRD4 recruits Cyclin T/CDK9 complex to phosphorylate RNA polymerase II carboxy terminal domain (Pol II CTD) and hence serves as a genome-wide activator of mRNA transcription (16–20) . Intriguingly, bromodomain and extraterminal domain (BET) inhibitors that specifically target BRD4 have shown to be selective antiproliferation compounds in the preclinical treatment of leukemia and solid tumors (9, 21–23) . In the opposite, protein phosphatase 2A (PP2A), a tumor suppressor, counteracts the BRD4-CDK9 axis to dephosphorylate Pol II C-terminal repeat domain (CTD) and attenuates global hypertranscription (24–26) .  \nHyperactivation of the oncogenic transcription reflects the epigenetic plasticity of the cancer cells, and it has been speculated that chromatin status permissive for transcription onset would favor the cancer cells sampling for the fitness genes to promote cell growth (2). However, the epigenetic factors that switch the chromatin status to prompt the global hypertranscription remain largely elusive.  \nThe nuclear oncogene Su(var)3-9, enhancer of zeste, Trithorax (SET; also called TAF-I) was first described as a nuclear factor that  \n1department of Pancreatic Surgery, Fudan University Shanghai cancer center, Shanghai 200032, china. 2department of Oncology, Shanghai Medical college, Fudan University, Shanghai 200032, china. 3Shanghai Pancreatic cancer institute, Shanghai 200032, china. 4Pancreatic cancer institute, Fudan University, Shanghai 200032, china. 5Key laboratory of Growth Regulation and translational Research of Zhejiang Province, School of life Sciences, Westlake University, 18 Shilongshan Road, hangzhou, Zhejiang Province 310024, china.  \n*[corresponding author. email: wudi@fudanpci.org](corresponding author. email: wudi@fudanpci.org) (d.W.); [yuxianjun@fudanpci.org](yuxianjun@fudanpci.org)  \n(X.Y.","cbCainq1rdnYIW0E","https://ap.wps.com/l/cbCainq1rdnYIW0E","pdf",2812995,"English","# Introduction\n## Nonmutational epigenetic reprogramming and hypertranscription\n## BRD4-CDK9 axis and the role of PP2A\n## SET as a transcription-associated factor with conflicting functions\n# Results\n## SET supported the RNA transcription\n## Transcriptome-matching strategy for candidate driver factors","[{\"question\":\"What question does the study address about SET-dependent transcription?\",\"answer\":\"The study asks what mechanisms underlie SET-dependent transcription, which have been unknown despite SET’s known association with chromatin-linked transcriptional activity.\"},{\"question\":\"How do SET and CDK9 relate based on transcriptome signatures?\",\"answer\":\"Overexpression of SET and CDK9 produces very similar transcriptome signatures across multiple cancer cell lines, suggesting convergence on a shared transcriptional program.\"},{\"question\":\"What role does PP2A play in the proposed mechanism?\",\"answer\":\"SET binds the PP2A-C subunit and disrupts PP2A-A/C interactions in transcription start site–proximal regions; blocking PP2A activity helps SET maintain Pol II CTD phosphorylation and activate mRNA transcription.\"}]","CANCER - PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells | PDF",1790012647,48]